Fennec Pharmaceuticals (FENC) Other financing activities (2014 - 2025)

Fennec Pharmaceuticals (FENC) has 10 years of Other financing activities data on file, last reported at $205000.0 in Q4 2025.

• Quarterly Other financing activities rose 146.7% year-over-year to $205000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (up 68.33% YoY) and the FY2025 annual result came in at $2.2 million, up 68.33% from the prior year.
• Other financing activities retreated to $205000.0 in Q4 2025, from $1.8 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $1.8 million in Q3 2025 to a low of -$439000.0 in Q4 2024.
• A 5-year average of $340875.0 and a median of $209000.0 in 2023 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2022 — Other financing activities sank 222.22% — and 2023, when it surged 6890.91%.
• Tracing FENC's Other financing activities over 5 years: stood at $9000.0 in 2021, then slumped by 222.22% to -$11000.0 in 2022, then surged by 6890.91% to $747000.0 in 2023, then tumbled by 158.77% to -$439000.0 in 2024, then soared by 146.7% to $205000.0 in 2025.
• The last three Other financing activities figures came in at $205000.0 (Q4 2025), $1.8 million (Q3 2025), and -$185000.0 (Q2 2025), per Business Quant data.